Aluminum Contamination in Parenteral Nutrition Admixtures for Low-Birth-Weight Preterm Infants in Mexico
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Background: Aluminum contamination from intravenous solutions still represents an unsolved clinical and biochemical problem. Increased aluminum intake constitutes a risk factor for the development to metabolic bone disease, anemia, cholestasis, and neurocognitive alterations. Low-birth-weight preterm infants (LBWPIs) are one of the most exposed populations for aluminum toxicity. Methods: To determine the presence of aluminum in components employed in the preparation of parenteral nutrition (PN) admixtures in Mexico and compare with the maximal aluminum recommended intake from the Food and Drug Administration. Results: Cysteine, trace elements, levocarnitine, phosphate, and calcium salts tested positive for aluminum contamination. All components analyzed were contained in glass vials. Total aluminum intake for 2 sample PN admixtures were calculated in basis to cover nutrition requirements of 2 hypothetical LBWPIs. Aluminum contents, stratified in micrograms per kilogram of weight, exceeded maximal aluminum recommendations, particularly for the very LBWPIs. Substituting sodium phosphate for potassium phosphate salts reduced aluminum intake by 52.7%25. Calcium gluconate was the leading aluminum contamination source and confers the greatest risk for aluminum overdose, even with the salt substitution of potassium phosphate by sodium phosphate salts. Adding cysteine and trace elements might increase aluminum content in PN admixtures. Conclusion: Cysteine, trace elements, phosphate, and gluconate salts are the main sources of aluminum in PN prepared in Mexico. Substituting sodium phosphate for potassium phosphate salts reduces aluminum intake but does not resolve aluminum contamination risk. Mineral salts contained in plastic vials should be explored as an additional measure to reduce aluminum contamination. © 2014 American Society for Parenteral and Enteral Nutrition.
publication date
published in
Research
keywords
-
aluminum; low-birth-weight preterm infants; metabolic bone disease; osteomalacia; parenteral nutrition; toxicity aluminum; calcium salt; carnitine; cysteine; gluconate calcium; phosphate; potassium dihydrogen phosphate; sodium dihydrogen phosphate; trace element; aluminum; carnitine; cysteine; parenteral solution; phosphate; potassium derivative; aluminum overload; Article; birth weight; dietary reference intake; food and drug administration; glass bottle; human; low birth weight; Mexico; newborn; nutritional requirement; parenteral nutrition; prematurity; priority journal; chemistry; drug contamination; infant; low birth weight; prematurity; United States; Aluminum; Calcium Gluconate; Carnitine; Cysteine; Drug Contamination; Humans; Infant; Infant, Low Birth Weight; Infant, Premature; Mexico; Nutritional Requirements; Parenteral Nutrition Solutions; Phosphates; Potassium Compounds; United States; United States Food and Drug Administration
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue